期刊文献+

姜黄素对小鼠S180肉瘤Ang-2和HIF-1α表达的影响 被引量:2

Effect of curcumin on the expression of Ang-2 and HIF-1α of S180 sarcoma in mice
下载PDF
导出
摘要 目的探讨姜黄素对肿瘤血管形成抑制作用机制。方法通过建立动物肿瘤模型,运用分别实验治疗,结合免疫组化,检测其肿瘤内血管密度以及瘤体Ang-2和HIF-1α的表达。结果姜黄素中剂量和大剂量姜黄素组的S180瘤体内微血管密度均明显低于对照组;免疫组化显示中剂量和大剂量姜黄素组可抑制S180瘤体内Ang-2和HIF-1α的表达。结论姜黄素对小鼠S180肉瘤血管形成有明显抑制作用,降低Ang-2和HIF-1α的表达可能是其抑制肿瘤血管形成的主要机制之一。 Objective To investigate inhibitory effect of curcumin on angiogenesis of S180 sarcoma in mice. Methods The vascular density of S180 sarcoma were tested in animal tumor model with experimental treatment. The expression of Ang-2 and HIF-1α were measured by immunohistochemistry. Results When the middle and high dose was used,the vascular density of S180 sarcoma was lower than that of control group. And the expression of Ang-2 and HIF-1α was down-regulated when the middle and high dose were used. Conclusion Cureumin has inhibitory effect on S180 sarcoma and inhibitory effects on angiogenesis. Its mechanism may be assioeiated with the down-regulating of the expression of Ang-2 and HIF-1α.
作者 黄冬生 张磊
出处 《中国实用医药》 2009年第15期60-61,共2页 China Practical Medicine
关键词 姜黄素 血管生成素-2 缺氧诱导因子-1Α Curcumin Angiopoietin-2 Hypoxia-inducible factor-1α
  • 相关文献

参考文献8

  • 1王坤.姜黄素药理学研究进展[J].中山大学研究生学刊(自然科学与医学版),2008,29(1):40-47. 被引量:13
  • 2Bosaris S,Lee AKC,Delellis RA,et al.Microvessel quantitation and prognosis in invasive breast carcinoma.Human Pathology,1992,23:755-761.
  • 3Rahman MA,Dhar DK,Yamaguchi E,et al.Coexpression of inducible nitric oxide synthase and cox-2 in hepatocellular carcinoma and surrounding liver:possible involvement of COX-2 in the angiogenesis of hepatitis C virus positive case.Clin Cancer Res,2001,7(5):1325-1332.
  • 4胡静,李立.姜黄素药理作用研究现状[J].检验医学与临床,2007,4(12):1186-1187. 被引量:20
  • 5Kunz M,Ibrahim SM.Molecular responses to hypoxia in tumor cells.Mol Cancer,2003,2(1):23.
  • 6Duffy JP,Eibl G,Reber HA,et al.Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer.Mol Cancer,2003,2:12.
  • 7Etoh T,Inoue H,Tnanka S,et al.Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma:possible in vivo regulation via induction of proteases.Cancer Res,2001,61:2145-2153.
  • 8Koga K,Todaka T,Moriolca M,et al.Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.Cancer Res,2001,61(16):6 248-254.

二级参考文献28

共引文献31

同被引文献21

  • 1赵东利,谢小卫,李明众,王书文.姜黄素对S180小鼠体内抗肿瘤作用的实验研究[J].西安交通大学学报(医学版),2007,28(1):70-73. 被引量:20
  • 2Jensen MA, van ′t Wout AB. Predicting HIV-1 coreceptor usage with sequence analysis. AIDS Rev, 2003, 5:104-112.
  • 3McGrath KM, Hoffman NG, Resch W, et al. Using HIV-1 sequence variability to explore virus biology. Virus Res, 2001, 76:137-160.
  • 4Resch W, Hoffman N, Swanstrom R. Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks. Virology, 2001, 288:51-62.
  • 5Cecilia D, KewalRamani VN, O′Leary J, et al. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J Virol, 1998, 72:6988-6996.
  • 6Morner A, Bjorndal A, Albert J, et al. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol, 1999, 73:2343-2349.
  • 7Peeters M, Liegeois F, Torimiro N, et al. Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol, 1999, 73:7368-7375.
  • 8Vodros D, Tscherning-Casper C, Navea L, et al. Quantitative evaluation of HIV-1 coreceptor use in the GHOST3 cell assay. Virology, 2001, 291:1-11.
  • 9Bures R, Morris L, Williamson C, et al. Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa. J Virol, 2002, 76:2233-2244.
  • 10Park EJ, Vujcic LK, Anand R, et al. Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes. J Virol, 1998, 72:7099-7107.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部